Cardiac and renal dysfunction in chronic heart failure: Relation to neurohumoral activation and prognosis

被引:27
作者
Marenzi, G [1 ]
Lauri, G [1 ]
Guazzi, M [1 ]
Assanelli, E [1 ]
Grazi, M [1 ]
Famoso, G [1 ]
Agostoni, P [1 ]
机构
[1] Univ Milan, Ctr Cardiol Monzino, IRCCS, Inst Cardiol, I-20138 Milan, Italy
关键词
heart failure; noradrenaline; plasma renin activity; aldosterone; renal function;
D O I
10.1097/00000441-200106000-00001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In chronic heart failure (CHF), cardiac dysfunction is considered the major determinant of neurohumoral activation but the role of renal impairment has not been defined. We investigated the relationship between both cardiac and renal dysfunction and neurohumoral activation, and their possible influence on prognosis. Methods: Hemodynamics, renal function, plasma neurohormones, and long-term follow-up were evaluated in 148 CHF patients, grouped according to systolic volume index (SVI) and serum creatinine (CRE) values: SVI > 28 mL/m(2) and CRE < 1.5 mg/dL(group I, n = 55), SVI < 28 mL/m2 and CRE < 1.5 mg/dL (group II, n = 37), SVI > 28 mL/m(2) and CRE > 1.5 mg/dL (group III, n = 25), SVI < 28 mL/m(2) and CRE > 1.5 mg/dL (group IV, n = 31). Results: Neurohormones progressively increased from Group I through IV and correlated with both cardiac and renal function. The hemodynamic pattern was similar in patients with normal or abnormal renal function, whereas neurohormones were only moderately increased in the former group and markedly increased in the latter group. Longterm survival progressively decreased from Group through IV and was significantly poorer in patients with renal dysfunction. Conclusions: Our study confirms that, in CHF, neurohumoral activation is strictly related to long-term survival and that many factors contribute to its development and progression; among these, cardiac and renal dysfunction seem to play a major role.
引用
收藏
页码:359 / 366
页数:8
相关论文
共 38 条
[31]   LONG-TERM PREDICTORS OF SUDDEN AND LOW OUTPUT DEATH IN CHRONIC CONGESTIVE HEART-FAILURE SECONDARY TO CORONARY-ARTERY DISEASE [J].
ROCKMAN, HA ;
JUNEAU, C ;
CHATTERJEE, K ;
ROULEAU, JL .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (19) :1344-1348
[32]   PREDICTING DEATH FROM PROGRESSIVE HEART-FAILURE SECONDARY TO ISCHEMIC OR IDIOPATHIC DILATED CARDIOMYOPATHY [J].
SAXON, LA ;
STEVENSON, WG ;
MIDDLEKAUFF, HR ;
FONAROW, G ;
WOO, M ;
MOSER, D ;
STEVENSON, LW .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (01) :62-65
[34]  
SHIMAI S-I, 1988, Japanese Journal of Geriatrics, V25, P610
[35]   HORMONES REGULATING CARDIOVASCULAR FUNCTION IN PATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE AND THEIR RELATION TO MORTALITY [J].
SWEDBERG, K ;
ENEROTH, P ;
KJEKSHUS, J ;
WILHELMSEN, L .
CIRCULATION, 1990, 82 (05) :1730-1736
[36]   PLASMA NOREPINEPHRINE IN CONGESTIVE HEART-FAILURE [J].
THOMAS, JA ;
MARKS, BH .
AMERICAN JOURNAL OF CARDIOLOGY, 1978, 41 (02) :233-243
[37]   ENDOGENOUS CATECHOLAMINE LEVELS IN CHRONIC HEART-FAILURE - RELATION TO THE SEVERITY OF HEMODYNAMIC ABNORMALITIES [J].
VIQUERAT, CE ;
DALY, P ;
SWEDBERG, K ;
EVERS, C ;
CURRAN, D ;
PARMLEY, WW ;
CHATTERJEE, K .
AMERICAN JOURNAL OF MEDICINE, 1985, 78 (03) :455-460
[38]  
WALSH PR, 1981, ANN CLIN LAB SCI, V11, P138